Post

Replies

Boosts

Views

Activity

Oct 2023: App submission stuck at In Review
I've seen other posts like this but most of them are years old. Our current submission is stuck at In Review and has been for a week. This is how it's gone: Submission 1: rejected within a day for a better demo video. We supplied the video and it was approved within a day. We pulled it before release for an update. Submission 2: rejected within a day for our FDA clearance evidence. We supplied that, and it was approved within a day. Submission 3: We found a late production bug just before we intended to release, so we pulled our approved submission and updated it with a new build that fixed the bug. We resubmitted with an expedite request. The expedite seemed to work as the app went to In Review status practically immediately, seeming to skip Waiting for Review. It's been a week since then, and we haven't been able to get any movement or meaningful response despite submitting requests for it. The thing is, a reviewer can't really run our app without our connected device. They can only examine their static analysis, watch our demo video, and read our FDA clearance information. What could possibly be going on for a week? We are at our wits end, and our patients need this app days ago. Has anyone found an avenue that actually works in these situations?
0
3
347
Oct ’23
Separate App versions per region
Due to our app having different government clearances in each geographical region, we are required to have a different version in each region. While the apps are all fundamentally the same, is there any reason we can't have: OurApp US - available in US OurApp UK - available in UK only OurApp EU - available in EU only While I understand how to implement this, there is concern that the subsequent submissions might be flagged incorrectly by the 4.3 Spam rule. Users would never see more than one version of our app in their region's App Store. Does anyone have any knowledge or experience here? Is this kind of release strategy acceptable?
0
4
648
Sep ’23